LORD PATRICK J 4

Accession 0000707549-24-000054

CIK 0000707549other

View on SEC.gov Company Profile

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 4:39 PM ET

Size

55.1 KB

Accession

0000707549-24-000054

Insider Transaction Report

Form 4

Period: 2024-03-11

LAM RESEARCH CORPLRCX

LORD PATRICK J

Executive Vice President

Transactions

Sale
Common Stock
2024-03-11$924.26/sh−300$277,278→ 9,692 total
Sale
Common Stock
2024-03-11$927.86/sh−325$301,555→ 8,837 total
Sale
Common Stock
2024-03-11$930.66/sh−204$189,855→ 8,166 total
Sale
Common Stock
2024-03-11$938.50/sh−25$23,463→ 7,966 total
Exercise/Conversion
Common Stock
2024-03-11$490.92/sh+1,407$690,724→ 9,373 total
Sale
Common Stock
2024-03-11$925.34/sh−80$74,027→ 8,938 total
Sale
Common Stock
2024-03-11$930.67/sh−63$58,632→ 8,169 total
Exercise/Conversion
Common Stock
2024-03-11$598.81/sh+1,362$815,579→ 9,328 total
Sale
Common Stock
2024-03-11$924.68/sh−300$277,404→ 9,028 total
Sale
Common Stock
2024-03-11$928.10/sh−121$112,300→ 8,318 total
Sale
Common Stock
2024-03-11$930.73/sh−101$94,004→ 8,094 total
Sale
Common Stock
2024-03-11$924.38/sh−355$328,155→ 9,018 total
Sale
Common Stock
2024-03-11$932.17/sh−106$98,810→ 8,063 total
Sale
Common Stock
2024-03-11$938.50/sh−17$15,955→ 7,966 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-03-11−1,362→ 0 total
Exercise: $598.81Exp: 2028-03-01→ Common Stock (1,362 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-03-11−2,026→ 1,013 total
Exercise: $540.57Exp: 2029-03-01→ Common Stock (2,026 underlying)
Sale
Common Stock
2024-03-11$929.63/sh−467$434,137→ 8,370 total
Sale
Common Stock
2024-03-11$934.18/sh−175$163,482→ 7,991 total
Sale
Common Stock
2024-03-11$929.62/sh−160$148,739→ 8,232 total
Sale
Common Stock
2024-03-11$925.78/sh−321$297,175→ 8,707 total
Sale
Common Stock
2024-03-11$927.00/sh−268$248,436→ 8,439 total
Sale
Common Stock
2024-03-11$929.25/sh−123$114,298→ 8,195 total
Sale
Common Stock
2024-03-11$939.93/sh−28$26,318→ 7,966 total
Exercise/Conversion
Common Stock
2024-03-11$540.57/sh+2,026$1,095,195→ 9,992 total
Sale
Common Stock
2024-03-11$925.29/sh−200$185,058→ 9,492 total
Sale
Common Stock
2024-03-11$926.67/sh−240$222,401→ 8,698 total
Sale
Common Stock
2024-03-11$928.64/sh−306$284,164→ 8,392 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-03-11−1,407→ 2,814 total
Exercise: $490.92Exp: 2030-03-01→ Common Stock (1,407 underlying)
Sale
Common Stock
2024-03-11$933.32/sh−100$93,332→ 7,994 total
Sale
Common Stock
2024-03-11$925.97/sh−330$305,570→ 9,162 total
Sale
Common Stock
2024-03-11$933.99/sh−80$74,719→ 7,983 total

Footnotes (23)

[F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 27, 2023.
[F10]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $925.09 to $925.49, inclusive.
[F11]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $925.62 to $926.47, inclusive.
[F12]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $927.26 to $928.20, inclusive.
[F13]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $929.23 to $930.00, inclusive.
[F14]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $930.47 to $930.85, inclusive.
[F15]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $934.05 to $934.35, inclusive.
[F16]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $923.79 to $924.71, inclusive.
[F17]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $926.47 to $927.02, inclusive.
[F18]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $928.21 to $929.05, inclusive.
[F19]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $930.30 to $930.98, inclusive.
[F2]The amount reported includes shares subject to unvested restricted stock units.
[F20]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $931.70 to $932.32, inclusive.
[F21]The stock options will become exercisable in three equal installments on 3/1/2022, 03/1/2023, and 3/2/2024.
[F22]The stock options will become exercisable in three equal installments on 3/1/2023, 03/1/2024, and 3/2/2025
[F23]The stock options will become exercisable in three equal installments on 03/01/2024, 03/01/2025, and 03/01/2026.
[F3]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $924.27 to $924.98, inclusive.
[F4]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $925.43 to $926.26, inclusive.
[F5]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $926.70 to $927.70, inclusive.
[F6]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $927.85 to $928.36, inclusive.
[F7]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $929.03 to $929.85, inclusive.
[F8]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $930.46 to $931.22, inclusive.
[F9]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $923.95 to $924.43, inclusive.

Documents

1 file

4
wk-form4_1710362370.xmlPrimary
FORM 4

Issuer

LAM RESEARCH CORP

CIK 0000707549

→

Entity typeother

Related Parties

filerCIK 0001343531

Filing Metadata

Form type: 4
Filed: Mar 12, 8:00 PM ET
Accepted: Mar 13, 4:39 PM ET
Size: 55.1 KB

View on SEC.gov